Not applicableUnknownNCT01302912What this trial is testingLymphoma in the OrbitWho this might be right forOcular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma University of Zurich 50
Early research (Phase 1)WithdrawnNCT00521261What this trial is testingDonor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT06510309What this trial is testingRituximab Plus Venetoclax in Front Line Marginal Zone LymphomaWho this might be right forLymphomaMarginal Zone LymphomaMZL Gottfried von Keudell, MD PhD 33
Early research (Phase 1)Ended earlyNCT01045928What this trial is testingLenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin LymphomaWho this might be right forAdult Non-Hodgkin LymphomaAdult Grade III Lymphomatoid GranulomatosisContiguous Stage II Adult Burkitt Lymphoma+77 more Case Comprehensive Cancer Center 5
Not applicableLooking for participantsNCT06043011What this trial is testingRegistry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic NeoplasmsWho this might be right forChronic Lymphocytic Leukemia (CLL)Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)+3 more iOMEDICO AG 2,950
Early research (Phase 1)Looking for participantsNCT05780034What this trial is testingAC676 for the Treatment of Relapsed/Refractory B-Cell MalignanciesWho this might be right forRelapsed/Refractory B-cell Malignancies Accutar Biotechnology Inc 60
Not applicableWithdrawnNCT01558778What this trial is testingMechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT02532257What this trial is testingIbrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone LymphomaWho this might be right forAnn Arbor Stage II Follicular LymphomaAnn Arbor Stage II Marginal Zone LymphomaAnn Arbor Stage III Follicular Lymphoma+7 more M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Ended earlyNCT00110149What this trial is testingRituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Beth Israel Deaconess Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT01474681What this trial is testingSafety and Tolerability of HSC835 in Patients With Hematological MalignanciesWho this might be right forAcute Myelocytic LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more Novartis Pharmaceuticals 27
Large-scale testing (Phase 3)Study completedNCT00750009What this trial is testingPersonalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Case Comprehensive Cancer Center 583
Not applicableStudy completedNCT00281814What this trial is testingCaregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more The Cleveland Clinic 36
Testing effectiveness (Phase 2)Study completedNCT00656812What this trial is testingRituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) LymphomaWho this might be right forLymphoma of Mucosa-Associated Lymphoid Tissue Arbeitsgemeinschaft medikamentoese Tumortherapie 40
Testing effectiveness (Phase 2)Ended earlyNCT05720052What this trial is testingMS-553 in Patients With Relapsed or Refractory B-cell LymphomaWho this might be right forRelapsed or Refractory B-cell LymphomaDiffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)+4 more MingSight Pharmaceuticals, Inc 8
Very early researchStudy completedNCT01239875What this trial is testingVaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin LymphomaWho this might be right forCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+13 more Mayo Clinic 16
Not applicableStudy completedNCT02945319What this trial is testingIntegrated Molecular and Clinical Profiling to Optimize Outcome Prediction in Splenic Marginal Zone LymphomaWho this might be right forSplenic Marginal Zone Lymphoma International Extranodal Lymphoma Study Group (IELSG) 373
Early research (Phase 1)Ended earlyNCT00176475What this trial is testingIrradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm University of Medicine and Dentistry of New Jersey 2
Not applicableStudy completedNCT00082654What this trial is testingStudy of the Emotional Needs of Caregivers of Stem Cell Transplantation PatientsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00054639What this trial is testingOblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin LymphomaWho this might be right forCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueIntraocular Lymphoma+18 more National Cancer Institute (NCI) 48
Early research (Phase 1)Ended earlyNCT05107856What this trial is testingPRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell MalignanciesWho this might be right forAcute Myeloid LeukemiaB-cell Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+7 more Prelude Therapeutics Incorporated 21